Regenerative biotechnology
CTM Exosomes
Exosomes derived from mesenchymal stem cells with immunomodulatory and regenerative activity.
Therapy of mesenchymal stem cell exosomes that modulate the inflammatory response, promote tissue regeneration, and support the control of autoimmune and degenerative processes.
Composition
Mesenchymal stem cell exosomes.
Pharmaceutical form
Injectable solution.
Monovette with 4 ml.
Monovette with 4 ml.
Therapeutic Properties
Immunomodulatory and anti-inflammatory activity through gene regulation; promotes tissue regeneration and cellular repair in inflammatory, autoimmune, and chronic-degenerative processes.
- Modulation of the inflammatory response.
- Reduction of autoimmune processes.
- Promotion of tissue regeneration.
- Support in chronic-degenerative diseases.
- Improvement of damaged tissue repair.
- Reduction of chronic inflammation.
- Adjuvant use in oncological therapies.
- Aplicación en procedimientos dermatocosméticos.
Mechanism of action & Clinical data
Phagocytosed micro vesicles that release micro-RNAs and proteins, regulating gene transcription, reducing proinflammatory pathways, and promoting an anti-inflammatory environment.